CtrlK
Coeptis Therapeutics Holdings
COEP49
$9.75arrow_drop_up2.84%$0.26
NASDAQ - As of Apr 4, 4:41 PM EDT Market Closed
High Growth
COEP49
$9.75
arrow_drop_up2.84%Performance History
There's no data available for performance history chart
There's no data available for key stats
There's no data available for ratios/profitability stats
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Predicted: just now
info
Analyzed by 9 Wall Street experts, Coeptis Therapeutics Holdings's 12-month projections average at $5.88, spanning from a high of $10.00 to a low of $3.00. This signifies an -38.50% shift from the current price of $9.75.
Analyst Ratings
There's no data available for Analyst Ratings
Last updated: -
• Total: -Correlated Companies
About Coeptis Therapeutics Holdings (COEP)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. David Mehalick
- Headquarters
- Wexford
- Employees
- 4
- Exchange
- NASDAQ
Keep an eye on Coeptis Therapeutics Holdings
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Coeptis Therapeutics Holdings's (COEP) price per share?
The current price per share for Coeptis Therapeutics Holdings (COEP) is $9.75. The stock has seen a price change of $0.27 recently, indicating a 2.85% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Coeptis Therapeutics Holdings (COEP)?
For Coeptis Therapeutics Holdings (COEP), the 52-week high is $15.16, which is 55.53% from the current price. The 52-week low is $0.13, the current price is 7.23K% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Coeptis Therapeutics Holdings (COEP) a growth stock?
Coeptis Therapeutics Holdings (COEP) has shown an average price growth of -1.65% over the past three years. It has received a score of 99 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Coeptis Therapeutics Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Coeptis Therapeutics Holdings (COEP) stock price performance year to date (YTD)?
As of the latest data, Coeptis Therapeutics Holdings (COEP) has a year-to-date price change of 77.27%. Over the past month, the stock has experienced a price change of -7.67%. Over the last three months, the change has been 70.45%. Over the past six months, the figure is 195.45%.
help
Is Coeptis Therapeutics Holdings (COEP) a profitable company?
Coeptis Therapeutics Holdings (COEP) has a net income of -$21.27M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$21.49M. Furthermore, the EBITDA is -$10.26M.
help
What is the market capitalization of Coeptis Therapeutics Holdings (COEP)?
Coeptis Therapeutics Holdings (COEP) has a market capitalization of $31.61M. The average daily trading volume is 9.59, indicating the stock's liquidity and investor engagement.